|
Chronic Myeloid Leukemia:
Featured Clinical Expert: |
|
| |
|
|
| |
Elias Jabbour, MD
The University of Texas
M. D. Anderson Cancer Center
Houston, Texas, United States
|
|
Missed a Recent Conversation?
Dr. Jabbour has responded to previous comments and questions. Click the link below to review.
CML Discussion: Week 1
CML Discussion: Week 2
CML Discussion: Week 3
CML Discussion: Week 4
CML Discussion: Week 5
CML Discussion: Week 6
CML Discussion: Week 7
CML Discussion: Week 8
CML Discussion: Week 9
Join the Current Conversation
CML Discussion: Week 10
|
|
|
| |
CML Discussion with Elias Jabbour, MD
|
|
|
|
Our patient was enrolled in a clinical trial and received an oral agent called X. A slight decrease in the WBC count was noticed after 2 weeks. After 4 weeks, he presented with a WBC count of 35000/μL, blasts 45%, platelet count of 65000/μL, and hemoglobin of 7.5 g/dL. What would you recommend at this stage?
|
|
|
Support for this activity has been provided by an unrestricted educational grant from Novartis Oncology.
|
|
